EHA 2022 – Shirley D’Sa
Shirley D’Sa discusses how the treatment and especially the prognosis of patients with WM evolved over the last decades, which approaches can be used to successfully treat patients with MYD88WTWM, how the interaction between WM cells and the bone marrow microenvironment can be used to develop new ways to overcome treatment resistance and finally explains how often the Binge-Neel Syndrome happens, how its diagnosed and how it should be treated.
Here is the full EHA 2022 report.
More posts
Preface – EHA 2022
After 2 years of the COVID-19 pandemic, the Annual Meeting of the American Society of Clinical Oncology, held in Chicago, USA, and virtually from 3rd–7th June 2022, featured nearly 250 oral as well as over 2,200 poster presentations. Shortly thereafter, the 27th Congress of the European Hematology Association 2022, held in Vienna, Austria, and virtually, from 9th–12th June 2022, saw leading experts from around the world gather again to further discuss the most exciting updates in the field of hematology with key updates summarized in 200 oral presentations and 1,400 posters.
